• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate (CAS No. 187035-79-6): A Key Intermediate in Modern Pharmaceutical Synthesis

Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate, identified by its CAS number 187035-79-6, is a highly valuable intermediate in the realm of pharmaceutical synthesis. This compound, characterized by its ethyl ester functionality and the presence of both chloro and trifluoromethyl substituents, plays a pivotal role in the development of various therapeutic agents. Its unique structural attributes make it an attractive building block for medicinal chemists aiming to design molecules with enhanced biological activity and improved pharmacokinetic properties.

The significance of Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate lies in its versatility as a precursor for synthesizing more complex pharmacophores. The trifluoromethyl group, in particular, is renowned for its ability to modulate metabolic stability, lipophilicity, and binding affinity, making it a staple in the design of drugs targeting a wide range of diseases. Recent advancements in synthetic methodologies have further highlighted the compound's utility, enabling more efficient and scalable production processes.

In the context of contemporary pharmaceutical research, Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate has been extensively explored in the synthesis of antiviral and anticancer agents. The pyrimidine core, a fundamental motif in nucleoside analogs, provides a scaffold that can be easily modified to incorporate additional functional groups. This flexibility has allowed researchers to develop novel compounds with potent inhibitory effects on viral enzymes and cancer cell proliferation pathways.

One notable application of this compound is in the development of inhibitors targeting the viral polymerase enzymes that are crucial for replication in certain RNA viruses. By leveraging the reactivity of the chloro and carboxylate groups, chemists have been able to design molecules that effectively interfere with viral replication cycles. These efforts have culminated in several promising candidates that are currently undergoing preclinical evaluation.

The incorporation of the trifluoromethyl group into these inhibitors has been particularly beneficial. This substituent not only enhances the metabolic stability of the compounds but also improves their binding affinity to target enzymes. As a result, drugs derived from Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate exhibit improved efficacy and reduced toxicity compared to their predecessors.

Another area where this compound has made significant contributions is in the field of oncology. Pyrimidine-based inhibitors have shown great promise in targeting various types of cancer by inhibiting key enzymes involved in DNA synthesis and repair. The structural features of Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate allow for the creation of molecules that selectively inhibit cancer cell proliferation while sparing healthy cells.

The< strong>Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate CAS No. 187035-79-6 has also been utilized in the synthesis of kinase inhibitors, which are essential for treating cancers driven by aberrant signaling pathways. By modifying the pyrimidine core with appropriate functional groups, researchers have been able to develop compounds that selectively inhibit specific kinases implicated in tumor growth and progression. These inhibitors have shown encouraging results in preclinical studies and are now being evaluated in clinical trials.

The growing interest in fluorinated compounds has further amplified the importance of Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate. Fluorochemicals are widely recognized for their ability to enhance drug properties such as bioavailability, metabolic stability, and cell membrane penetration. The< strong >trifluoromethylgroup, being a prime example of a fluorinated moiety, has been incorporated into numerous drugs that have reached the market over the past decade.

In conclusion, Ethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate is a multifaceted intermediate with broad applications in pharmaceutical synthesis. Its unique structural features and reactivity make it an indispensable tool for medicinal chemists working on antiviral and anticancer agents. As research continues to uncover new therapeutic targets and synthetic strategies, the demand for this compound is expected to grow further, solidifying its role as a cornerstone in modern drug discovery.

• 149771-09-5(Ethyl 2-amino-4-(trifluoromethyl)pyrimidine-5-carboxylate)
• 188781-15-9(2,4-Bis-(trifluoromethyl)pyrimidine-5-carboxylic Acid Ethyl Ester)
• 175137-30-1(Cyclopropylmethyl 2-chloro-4-(trifluoromethyl)-5-pyrimidinecarboxylate)
• 149771-10-8(Ethyl 2-methyl-4-(trifluoromethyl)pyrimidine-5-carboxylate)
• 306960-67-8(Ethyl 4-methyl-2-(trifluoromethyl)pyrimidine-5-carboxylate)
• 175137-31-2(Cyclopropylmethyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate)
• 188781-17-1(2-Chloro-4-(trifluoromethyl)pyrimidine-5-carboxylic acid)
• 175137-29-8(Benzyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate)
• 175137-27-6(Methyl 2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate)
• 187035-81-0(Ethyl 4-(trifluoromethyl)pyrimidine-5-carboxylate)